Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Oncocyte Corporation - Common Stock
(NQ:
OCX
)
2.190
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 20, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
2.190
Bid (Size)
2.190 (5)
Ask (Size)
2.230 (2)
Prev. Close
2.190
Today's Range
2.190 - 2.190
52wk Range
1.980 - 3.820
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
OCX Stock Earnings: OncoCyte Misses EPS, Misses Revenue for Q1 2024
May 15, 2024
OCX stock results show that OncoCyte missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.
Via
InvestorPlace
3 Penny Stocks That Insiders Are Buying
May 07, 2024
Penny stocks are a risky business but following the insiders to your next trade can alleviate some of the risks; these are the three hottest insider buys.
Via
MarketBeat
Performance
YTD
-33.64%
-33.64%
1 Month
-19.19%
-19.19%
3 Month
-30.48%
-30.48%
6 Month
-17.36%
-17.36%
1 Year
-13.44%
-13.44%
More News
Read More
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
April 23, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
April 15, 2024
Via
InvestorPlace
OncoCyte's Earnings: A Preview
November 08, 2023
Via
Benzinga
Oncocyte's VitaGraftTM Kidney Identifies Transplant Rejection 10 Months Earlier
September 18, 2023
Via
ACCESSWIRE
Earnings Scheduled For November 12, 2024
November 12, 2024
Via
Benzinga
What to Expect from OncoCyte's Earnings
November 11, 2024
Via
Benzinga
OCX Stock Earnings: OncoCyte Beats EPS, Misses Revenue for Q2 2024
August 08, 2024
Via
InvestorPlace
OncoCyte’s (NASDAQ:OCX) Innovative Approach: Potential in Precision Diagnostics
June 05, 2024
Via
AB Newswire
OncoCyte's Innovative Approach: Potential in Precision Diagnostics
June 05, 2024
Via
News Direct
OncoCyte's Innovative Approach: Potential in Precision Diagnostics
June 05, 2024
Via
TheNewswire.com
4 Analysts Assess OncoCyte: What You Need To Know
May 16, 2024
Via
Benzinga
Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session
April 15, 2024
Via
Benzinga
Why Medical Properties Trust Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket
April 15, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
April 12, 2024
Via
Benzinga
OCX Stock Earnings: OncoCyte Misses EPS, Misses Revenue for Q4 2023
April 12, 2024
Via
InvestorPlace
Top 3 Health Care Stocks That May Collapse In Q2
April 12, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
April 12, 2024
Via
InvestorPlace
Earnings Scheduled For April 12, 2024
April 12, 2024
Via
Benzinga
Why NextPlat Shares Are Trading Higher By Around 30%; Here Are 20 Stocks Moving Premarket
April 12, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
November 09, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
November 09, 2023
Via
Benzinga
Why AMC Entertainment Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
November 09, 2023
Via
Benzinga
Why Owens Corning Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
October 25, 2023
Via
Benzinga
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.